EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $912,000 | -35.9% | 22,628 | +10.2% | 0.03% | -35.3% |
Q3 2018 | $1,423,000 | -47.0% | 20,527 | -42.1% | 0.05% | -48.0% |
Q2 2018 | $2,683,000 | +142.4% | 35,459 | +68.8% | 0.10% | +127.9% |
Q1 2018 | $1,107,000 | -93.0% | 21,007 | -89.6% | 0.04% | -93.8% |
Q2 2017 | $15,928,000 | +46.9% | 201,904 | +54.5% | 0.69% | +31.2% |
Q1 2017 | $10,842,000 | – | 130,719 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |